InxMed (Shanghai) Co., Ltd.   Report issue

For profit Phase 1 Phase 2
Founded: Shanghai China (2018)

Organization Overview

First Clinical Trial
2019
NCT04109456
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2023

Timeline

NOW
  • Now

Alternative names

InxMed (Shanghai) Co., Ltd.